# Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

> **NCT01186419** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 51 (actual)

## Conditions studied

- Transfusional Iron Overload
- Beta-thalassemia

## Interventions

- **DRUG:** SPD602 (FBS0701, SSP-004184)

## Key facts

- **NCT ID:** NCT01186419
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-13
- **Primary completion:** 2013-01-08
- **Final completion:** 2013-01-08
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2021-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01186419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01186419, "Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01186419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*